Woodmont Investment Counsel’s W.W. Grainger GWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$445K Buy
327
+2
+0.6% +$2.46K 0.02% 210
2026
Q1
$355K Buy
325
+6
+2% +$6.55K 0.02% 217
2025
Q4
$322K Buy
319
+1
+0.3% +$970 0.02% 219
2025
Q3
$303K Sell
318
-28
-8% -$28.1K 0.02% 223
2025
Q2
$360K Buy
346
+2
+0.6% +$2.08K 0.02% 224
2025
Q1
$340K Buy
344
+3
+0.9% +$3.1K 0.02% 221
2024
Q4
$359K Hold
341
0.03% 211
2024
Q3
$354K Hold
341
0.03% 212
2024
Q2
$308K Hold
341
0.03% 214
2024
Q1
$347K Sell
341
-1
-0.3% -$932 0.03% 205
2023
Q4
$283K Buy
342
+27
+9% +$20.8K 0.03% 212
2023
Q3
$218K Hold
315
0.02% 222
2023
Q2
$248K Hold
315
0.03% 213
2023
Q1
$217K Buy
+315
New +$201K 0.02% 229
2016
Q4
Sell
-250
Closed -$56K 363
2016
Q3
$56K Buy
+250
New +$56.2K 0.02% 251
2016
Q2
Sell
-250
Closed -$58K 298
2016
Q1
$58K Hold
250
0.02% 245
2015
Q4
$51K Hold
250
0.02% 260
2015
Q3
$54K Hold
250
0.02% 252
2015
Q2
$59K Buy
+250
New +$60.6K 0.02% 245

Other funds holding GWW

Woodmont Investment Counsel's GWW Position: Q2 2026 in Review

Woodmont Investment Counsel increased its W.W. Grainger (GWW) stake by 0.62% in Q2 2026, buying an estimated $2.46K and bringing the position to 327 shares worth $445K. The position accounts for 0.02% of the portfolio, ranked #210.

Woodmont Investment Counsel first reported a position in GWW in Q2 2015 and has held it in 19 quarters since. 637 funds tracked by Wall St. Rank hold GWW as of Q2 2026.

  • Woodmont Investment Counsel held 327 shares of W.W. Grainger worth $445K as of Q2 2026.
  • Woodmont Investment Counsel bought 2 W.W. Grainger shares in Q2 2026, an estimated $2.46K.
  • W.W. Grainger made up 0.02% of Woodmont Investment Counsel's portfolio in Q2 2026, its #210 holding.
  • Woodmont Investment Counsel first reported a position in W.W. Grainger in Q2 2015 and has held it in 19 quarters since.
  • 637 funds tracked by Wall St. Rank held W.W. Grainger as of Q2 2026.

Based on Woodmont Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.